Statistics
Publications
45
Citations
9K
H-Index
34
Active since
1984
Samuel H. Zwillich is an author at Pfizer (United States) specializing in medicine, rheumatology, and pharmacology.
Publications per year
1984–2025
45
45
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Ronald van Vollenhoven, Roy Fleischmann, Stanley Cohen et al. · New England Journal of Medicine · 2012 · 939 citations · Full text
Medicine, Immunology, Pharmacology +13
Tofacitinib versus Methotrexate in Rheumatoid Arthritis
Eun Bong Lee, Roy Fleischmann, Stephen Hall et al. · New England Journal of Medicine · 2014 · 774 citations · Full text
Gerd R Burmester, Ricardo Blanco, Christina Charles‐Schoeman et al. · The Lancet · 2013 · 720 citations
Désirée van der Heijde, Yoshiya Tanaka, Roy Fleischmann et al. · Arthritis & Rheumatism · 2013 · 582 citations
1–5 of 45